J. Ellmén
Orion Corporation
Orion Pharma
Clinical R & D
Turku
Finland
Name/email consistency: high
- Dose-dependent hormonal effects of toremifene in postmenopausal breast cancer patients. Ellmén, J., Werner, D., Hakulinen, P., Keiling, R., Fargeot, P., Falkson, G., Bezwoda, W.R. Cancer Chemother. Pharmacol. (2000)